Skip to main content
SpringerLink
Log in
Book cover

Aging and Lung Disease pp 201–226Cite as

Interstitial Lung Disease in Older Patients

  • Chapter
  • First Online:

  • 1198 Accesses

Part of the book series: Respiratory Medicine ((RM))

Abstract

The term interstitial lung disease (ILD), sometimes also called diffuse parenchymal lung disease (DPLD), refers to a heterogeneous group of lung disorders that share clinical, radiographic, and pathologic features. Prognosis and decisions regarding therapy depend upon a specific diagnosis being made from within this large category of disease. Diagnosis is based upon a careful history, detailed physical examination, as well as review of laboratory data, physiologic studies, radiography, and in some cases, pathologic tissue. Frequently, review at a multidisciplinary conference is necessary. While certain diseases vary in incidence and prevalence by age, the approach to interstitial lung disease in the older patient is similar to that in younger patients. Decisions regarding diagnostic approach and therapy must be individualized based upon the patient’s respiratory status, comorbid medical conditions, and personal desires.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wade 3rd JF, King Jr TE. Infiltrative and interstitial lung disease in the elderly patient. Clin Chest Med. 1993;14:501.

    PubMed  Google Scholar 

  2. Meyer KC, Decker C, Baughman R. Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases. Clin Chest Med. 2010;31:565.

    Article  PubMed  Google Scholar 

  3. Homer RJ, Herzog EL. Recent advances in pulmonary fibrosis: implications for scleroderma. Curr Opin Rheumatol. 2010;22:683.

    Article  PubMed  CAS  Google Scholar 

  4. Naidoo N. ER and aging-protein folding and the ER stress response. Ageing Res Rev. 2009;8:150.

    Article  PubMed  CAS  Google Scholar 

  5. Castriotta RJ, Eldadah BA, Foster WM, et al. Workshop on idiopathic pulmonary fibrosis in older adults. Chest. 2010;138:693.

    Article  PubMed  Google Scholar 

  6. Naidoo N. The endoplasmic reticulum stress response and aging. Rev Neurosci. 2009;20:23.

    PubMed  CAS  Google Scholar 

  7. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc. 2006;3:364.

    Article  PubMed  CAS  Google Scholar 

  8. Selman M, Rojas M, Mora AL, et al. Aging and interstitial lung diseases: unraveling an old forgotten player in the pathogenesis of lung fibrosis. Semin Respir Crit Care Med. 2010;31:607.

    Article  PubMed  Google Scholar 

  9. Hornsby PJ. Telomerase and the aging process. Exp Gerontol. 2007;42:575.

    Article  PubMed  CAS  Google Scholar 

  10. Marciniak RA, Johnson FB, Guarente L. Dyskeratosis congenita, telomeres and human ageing. Trends Genet. 2000;16:193.

    Article  PubMed  CAS  Google Scholar 

  11. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;178:729.

    Article  PubMed  CAS  Google Scholar 

  12. Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA. 2008;105:13051.

    Article  PubMed  CAS  Google Scholar 

  13. Nicholson AG. Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup. Histopathology. 2002;41:381.

    Article  PubMed  CAS  Google Scholar 

  14. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2001;165:277.

    Google Scholar 

  15. Schwarz MI, Cosgrove GP. Approach to the evaluation and diagnosis of interstitial lung disease. In: Interstitial lung disease. 5th ed. Sheltan CT People Medical Publishing House, USA, 2011, pp. 3–25

    Google Scholar 

  16. James D. Sarcoidosis of the respiratory system. Semin Respir Med. 1986;8:1.

    Article  Google Scholar 

  17. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med. 2007;28:369.

    Article  PubMed  Google Scholar 

  18. Franquet T, Gimenez A, Torrubia S, et al. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol. 2000;10:108.

    Article  PubMed  CAS  Google Scholar 

  19. Mendez JL, Nadrous HF, Vassallo R, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest. 2004;125:1028.

    Article  PubMed  Google Scholar 

  20. Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137:1164.

    Article  PubMed  Google Scholar 

  21. Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2007;31:442.

    Article  Google Scholar 

  22. Sorenson EJ, Crum B, Stevens JC. Incidence of aspiration pneumonia in ALS in Olmsted County, MN. Amyotroph Lateral Scler. 2007;8:87.

    Article  PubMed  Google Scholar 

  23. Kradin RL, Digumarthy SR, Baggish AL, et al. Case records of the Massachusetts General Hospital. Case 12–2010. An 89-year-old man with progressive dyspnea. N Engl J Med. 2010;362:1522.

    Article  PubMed  CAS  Google Scholar 

  24. Fontenot AP, Amicosante M. Metal-induced diffuse lung disease. Semin Respir Crit Care Med. 2008;29:662.

    Article  PubMed  Google Scholar 

  25. Rake C, Gilham C, Hatch J, et al. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 2009;100:1175.

    Article  PubMed  CAS  Google Scholar 

  26. Camus P, Bonniaud P, Fanton A, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004;25:479.

    Article  PubMed  Google Scholar 

  27. Hardak E, Berger G, Krivoy N, et al. Nitrofurantoin pulmonary toxicity: neglected threat. Curr Drug Saf. 2010;5:125.

    Article  PubMed  CAS  Google Scholar 

  28. Camus P, Martin 2nd WJ, Rosenow 3rd EC. Amiodarone pulmonary toxicity. Clin Chest Med. 2004;25:65.

    Article  PubMed  Google Scholar 

  29. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003;124:1215.

    Article  PubMed  Google Scholar 

  30. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J. 2002;19:275.

    Article  PubMed  CAS  Google Scholar 

  31. Schmidt SL, Sundaram B, Flaherty KR. Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis? Respirology. 2009;14:934.

    Article  PubMed  Google Scholar 

  32. Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236:10.

    Article  PubMed  Google Scholar 

  33. Copley SJ, Wells AU, Hawtin KE, et al. Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old. Radiology. 2009;251:566.

    Article  PubMed  Google Scholar 

  34. Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004;25:549.

    Article  PubMed  Google Scholar 

  35. Villalba WO, Sampaio-Barros PD, Pereira MC, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131:217.

    Article  PubMed  Google Scholar 

  36. Caminati A, Harari S. IPF: new insight in diagnosis and prognosis. Respir Med. 2010;104 Suppl 1:S2.

    Article  PubMed  Google Scholar 

  37. D’Ippolito R, Foresi A, Castagnetti C, et al. Indications for flexible fiberoptic bronchoscopy and its safety in the very elderly. Monaldi Arch Chest Dis. 2007;67:23.

    PubMed  Google Scholar 

  38. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007;28:546.

    Article  PubMed  Google Scholar 

  39. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997;10:2716.

    Article  PubMed  CAS  Google Scholar 

  40. Welker L, Jorres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004;24:1000.

    Article  PubMed  CAS  Google Scholar 

  41. Meyer KC, Rosenthal NS, Soergel P, et al. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev. 1998;104:169.

    Article  PubMed  CAS  Google Scholar 

  42. Cordeiro CR, Jones JC, Alfaro T, et al. Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med. 2007;28:504.

    Article  PubMed  Google Scholar 

  43. Auerswald U, Barth J, Magnussen H. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung. 1991;169:305.

    Article  PubMed  CAS  Google Scholar 

  44. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25:637.

    Article  PubMed  Google Scholar 

  45. Ramirez P, Valencia M, Torres A. Bronchoalveolar lavage to diagnose respiratory infections. Semin Respir Crit Care Med. 2007;28:525.

    Article  PubMed  Google Scholar 

  46. Lee BE, Robinson JL, Khurana V, et al. Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests. J Med Virol. 2006;78:702.

    Article  PubMed  CAS  Google Scholar 

  47. Azoulay E, Bergeron A, Chevret S, et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135:655.

    Article  PubMed  CAS  Google Scholar 

  48. Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, et al. Safety of the transbronchial biopsy in outpatients. Chest. 1991;99:562.

    Article  PubMed  CAS  Google Scholar 

  49. Alzeer AH, Al-Otair HA, Al-Hajjaj MS. Yield and complications of flexible fiberoptic bronchoscopy in a teaching hospital. Saudi Med J. 2008;29:55.

    PubMed  Google Scholar 

  50. Leslie KO, Gruden JF, Parish JM, et al. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med. 2007;131:407.

    PubMed  Google Scholar 

  51. Wall CP, Gaensler EA, Carrington CB, et al. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis. 1981;123:280.

    PubMed  CAS  Google Scholar 

  52. Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol. 2008;39:1275.

    Article  PubMed  Google Scholar 

  53. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003;58:143.

    Article  PubMed  CAS  Google Scholar 

  54. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177:433.

    Article  PubMed  Google Scholar 

  55. Riley DJ, Costanzo EJ. Surgical biopsy: its appropriateness in diagnosing interstitial lung disease. Curr Opin Pulm Med. 2006;12:331.

    Article  PubMed  Google Scholar 

  56. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:193.

    PubMed  CAS  Google Scholar 

  57. Jaklitsch MT, Pappas-Estocin A, Bueno R. Thoracoscopic surgery in elderly lung cancer patients. Crit Rev Oncol Hematol. 2004;49:165.

    Article  PubMed  Google Scholar 

  58. Chang AC, Yee J, Orringer MB, et al. Diagnostic thoracoscopic lung biopsy: an outpatient experience. Ann Thorac Surg. 2002;74:1942.

    Article  PubMed  Google Scholar 

  59. Kreider ME, Hansen-Flaschen J, Ahmad NN, et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg. 2007;83:1140.

    Article  PubMed  Google Scholar 

  60. Carrillo G, Estrada A, Pedroza J, et al. Preoperative risk factors associated with mortality in lung biopsy patients with interstitial lung disease. J Invest Surg. 2005;18:39.

    Article  PubMed  CAS  Google Scholar 

  61. Lettieri CJ, Veerappan GR, Helman DL, et al. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005;127:1600.

    Article  PubMed  Google Scholar 

  62. Hazelrigg SR, Nunchuck SK, LoCicero 3rd J. Video Assisted Thoracic Surgery Study Group data. Ann Thorac Surg. 1993;56:1039.

    Article  PubMed  CAS  Google Scholar 

  63. Jaklitsch MT, DeCamp Jr MM, Liptay MJ. Video-assisted thoracic surgery in the elderly. A review of 307 cases. Chest. 1996;110:751.

    Article  PubMed  CAS  Google Scholar 

  64. Jaklitsch M, Billmeier S. Preoperative evaluation and risk assessment for elderly thoracic surgery patients. Thorac Surg Clin. 2009;19:301.

    Article  PubMed  Google Scholar 

  65. Hanna MN, Murphy JD, Kumar K, et al. Postoperative pain management in the elderly undergoing thoracic surgery. Thorac Surg Clin. 2009;19:353.

    Article  PubMed  Google Scholar 

  66. Flaherty KR, King Jr TE, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904.

    Article  PubMed  Google Scholar 

  67. Flaherty KR, Andrei AC, King Jr TE, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007;175:1054.

    Article  PubMed  Google Scholar 

  68. Craig TJ, Hershey J, Engler RJ, et al. Bird antigen persistence in the home environment after removal of the bird. Ann Allergy. 1992;69:510.

    PubMed  CAS  Google Scholar 

  69. Girard M, Lacasse Y, Cormier Y. Hypersensitivity pneumonitis. Allergy. 2009;64:322.

    Article  PubMed  CAS  Google Scholar 

  70. Glazer CS, Rose CS, Lynch DA. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging. 2002;17:261.

    Article  PubMed  Google Scholar 

  71. Gogali A, Wells AU. New pharmacological strategies for the treatment of pulmonary fibrosis. Ther Adv Respir Dis. 2010;4(6):353–66.

    Article  PubMed  CAS  Google Scholar 

  72. Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 2010;49:239.

    Article  PubMed  CAS  Google Scholar 

  73. Busse PJ, Kilaru K. Complexities of diagnosis and treatment of allergic respiratory disease in the elderly. Drugs Aging. 2009;26:1.

    Article  PubMed  Google Scholar 

  74. Cutolo M, Seriolo B, Pizzorni C, et al. Use of glucocorticoids and risk of infections. Autoimmun Rev. 2008;8:153.

    Article  PubMed  CAS  Google Scholar 

  75. Seibold JR, Denton CP, Furst DE, et al. Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum. 2010;62:2101.

    Article  PubMed  CAS  Google Scholar 

  76. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353:2229.

    Article  PubMed  CAS  Google Scholar 

  77. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1.

    PubMed  Google Scholar 

  78. Clark M, Cooper B, Singh S, et al. A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Thorax. 2001;56:482.

    Article  PubMed  CAS  Google Scholar 

  79. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390.

    Article  PubMed  Google Scholar 

  80. Laviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax. 2008;63:115.

    Article  PubMed  CAS  Google Scholar 

  81. Swigris JJ, Brown KK, Make BJ, et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102:1675.

    Article  PubMed  Google Scholar 

  82. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev. 2008;CD006322.

    Google Scholar 

  83. Singer HK, Ruchinskas RA, Riley KC, et al. The psychological impact of end-stage lung disease. Chest. 2001;120:1246.

    Article  PubMed  CAS  Google Scholar 

  84. Ponnuswamy A, Manikandan R, Sabetpour A, et al. Association between ischaemic heart disease and interstitial lung disease: a case-control study. Respir Med. 2009;103:503.

    Article  PubMed  CAS  Google Scholar 

  85. Nathan SD, Basavaraj A, Reichner C, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med. 2010;104:1035.

    Article  PubMed  Google Scholar 

  86. Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136:772.

    Article  PubMed  Google Scholar 

  87. Mermigkis C, Stagaki E, Tryfon S, et al. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath. 2010;14(4):387–90.

    Article  PubMed  Google Scholar 

  88. Rasche K, Orth M. Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol. 2009;60 Suppl 5:13–4.

    PubMed  Google Scholar 

  89. Tobin RW, Pope 2nd CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158:1804.

    PubMed  CAS  Google Scholar 

  90. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136.

    Article  PubMed  CAS  Google Scholar 

  91. Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest. 2006;129:794.

    Article  PubMed  Google Scholar 

  92. Patel NM, Lederer DJ, Borczuk AC, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest. 2007;132:998.

    Article  PubMed  Google Scholar 

  93. Corte TJ, Wort SJ, Wells AU. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:7.

    PubMed  CAS  Google Scholar 

  94. Hassoun PM. Pulmonary arterial hypertension complicating connective tissue diseases. Semin Respir Crit Care Med. 2009;30:429.

    Article  PubMed  Google Scholar 

  95. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137:674.

    Article  PubMed  Google Scholar 

  96. Abrahm JL, Hansen-Flaschen J. Hospice care for patients with advanced lung disease. Chest. 2002;121:220.

    Article  PubMed  Google Scholar 

  97. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177:912.

    Article  PubMed  Google Scholar 

  98. Merlo CA, Orens JB. Candidate selection, overall results, and choosing the right operation. Semin Respir Crit Care Med. 2010;31:99.

    Article  PubMed  Google Scholar 

  99. Weiss ES, Merlo CA, Shah AS. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data. J Am Coll Surg. 2009;208:400.

    Article  PubMed  Google Scholar 

  100. Russo MJ, Davies RR, Hong KN, et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009;138:1234.

    Article  PubMed  Google Scholar 

  101. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic ­pulmonary fibrosis. Ann Intern Med. 2005;142:963.

    PubMed  Google Scholar 

  102. O’Beirne S, Counihan IP, Keane MP. Interstitial lung disease and lung transplantation. Semin Respir Crit Care Med. 2010;31:139.

    Article  PubMed  Google Scholar 

  103. Mogulkoc N, Brutsche MH, Bishop PW, et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001;164:103.

    PubMed  CAS  Google Scholar 

  104. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531.

    Article  PubMed  Google Scholar 

  105. Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:659.

    Article  PubMed  Google Scholar 

  106. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. 2006;174:803.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, 15 Yaork Street, LLCI 101, New Haven, CT, 6510, USA

    Danielle Antin-Ozerkis

Authors
  1. Danielle Antin-Ozerkis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danielle Antin-Ozerkis .

Editor information

Editors and Affiliations

  1. School of Medicine, Pulmonary and Critical Care Medicine, Yale University, Cedar Street 330, New Haven, 06520-8057, Connecticut, USA

    Margaret Pisani

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Antin-Ozerkis, D. (2012). Interstitial Lung Disease in Older Patients. In: Pisani, M. (eds) Aging and Lung Disease. Respiratory Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-727-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-727-3_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-726-6

  • Online ISBN: 978-1-60761-727-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation